Riskpilot← Back to searchSign inGet full accessGN HEARING NORWAY AS
ASActiveOrg 912920437Brynsveien 13, 0667 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 196716 employees
Revenue 2024
NOK 81,1M
+13% vs 2023
EBITDA margin
3.5%
-3% vs 2023
Equity ratio
9.2%
Financial strength
Net profit 2024
NOK 2,1M
-11% vs 2023
| Revenue | NOK 81,1M | +13% |
| EBITDA | NOK 2,8M | -3% |
| Net profit | NOK 2,1M | -11% |
| Total assets | NOK 53,9M | +9% |
| Equity | NOK 5M | +76% |
| Employees | 16 | — |
Legal name
GN HEARING NORWAY AS
Org number
912920437
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. januar 1967
Share capital
—
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Formålet er handel og agenturvirksomhet, herunder salg av hodetelefoner, og eventuelt overtagelse av økonomiske interesser i andre foretagender, og tilhørende aktiviteter.
Address
Brynsveien 13, 0667 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 94 208 | 78 585 | 63 106 | 72 054 | 81 098 |
| Staff expenses | −15 035 | −12 296 | −11 536 | −9 773 | −10 524 |
| EBITDA | 3 098 | 2 797 | 2 518 | 2 919 | 2 838 |
| Depreciation & amort. | −41 | −0 | −0 | −0 | −0 |
| EBIT | 3 057 | 2 797 | 2 518 | 2 919 | 2 838 |
| Net financials | −783 | −409 | −518 | 134 | −120 |
| Profit before tax | 2 273 | 2 388 | 2 000 | 3 053 | 2 719 |
| Tax | 523 | 562 | 503 | 701 | 627 |
| Net profit | 1 750 | 1 826 | 1 497 | 2 352 | 2 091 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 38 856 | 40 430 | 29 592 | 49 306 | 53 941 |
| Equity | 6 825 | 8 817 | 10 944 | 2 829 | 4 977 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 30 621 | 30 506 | 17 746 | 45 658 | 47 995 |
| Total debt | 30 621 | 30 506 | 17 746 | 45 658 | 47 995 |
EBITDA margin
3.5%
This company
15.8%
Market median
-78% vs market
20202024
Equity ratio
9.2%
This company
38.2%
Market median
-76% vs market
20202024
Return on equity
42.0%
This company
18.4%
Market median
+128% vs market
20202024
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20202024
Asset turnover
1.50×
This company
1.12×
Market median
+34% vs market
20202024
Debt / equity
9.84×
This company
0.62×
Market median
-1487% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IT Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (5) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Chairman | 2021 – 2022 | |
| Chairman | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Gn Resound As | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GN HEARING NORWAY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ivar Thomsen | Chief Executive Officer | 0 companies |
| Mikkel Carlsen Skovsted | Board of Directors | 0 companies |
| Anders Høst Lassen | Board of Directors | 0 companies |
| Bredo Berge | Chairman | 0 companies |
| Stefan Olivier Witschi | Chairman | 0 companies |
| Paul Gilbert Daft | Board of Directors | 0 companies |
| Peter Justesen | Chairman | 0 companies |
| Victor Ullerichs | Board of Directors | 0 companies |
| Thomas John Woods | Board of Directors | 0 companies |